|
1
|
Guo QL, You QD, Wu ZQ, Yuan ST and Zhao L:
General gambogic acids inhibited growth of human hepatoma SMMC-7721
cells in vitro and in nude mice. Acta Pharmacol Sin. 25:769–774.
2004.PubMed/NCBI
|
|
2
|
Qin Y, Meng L, Hu C, Duan W, Zuo Z, Lin L,
Zhang X and Ding J: Gambogic acid inhibits the catalytic activity
of human topoisomerase IIalpha by binding to its ATPase domain. Mol
Cancer Ther. 6:2429–2440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geng J, Xiao S, Zheng Z, Song S and Zhang
L: Gambogic acid protects from endotoxin shock by suppressing
pro-inflammatory factors in vivo and in vitro. Inflamm Res.
62:165–172. 2013. View Article : Google Scholar
|
|
4
|
Lu N, Hui H, Yang H, Zhao K, Chen Y, You
QD and Guo QL: Gambogic acid inhibits angiogenesis through
inhibiting PHD2-VHL-HIF-1α pathway. Eur J Pharm Sci. 49:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xin ZF, Shen CC, Tao LJ, Yan SG and Wu HB:
Gambogic acid inhibits invasion of osteosarcoma via upregulation of
TIMP-1. Int J Mol Med. 31:105–112. 2013.
|
|
6
|
Wang LH, Yang JY, Yang SN, Li Y, Ping GF,
Hou Y, Cui W, Wang ZZ, Xiao W and Wu CF: Suppression of NF-κB
signaling and P-glycoprotein function by gambogic acid
synergistically potentiates adriamycin-induced apoptosis in lung
cancer. Curr Cancer Drug Targets. 14:91–103. 2014. View Article : Google Scholar
|
|
7
|
Duan D, Zhang B, Yao J, Liu Y, Sun J, Ge
C, Peng S, Fang J, Xiao W and Wu CF: Gambogic acid induces
apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting
cytosolic thioredoxin reductase. Free Radic Biol Med. 69:15–25.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu X, Liu Y, Wang L, He J, Zhang H, Chen
X, Li Y, Yang J and Tao J: Gambogic acid induces apoptosis by
regulating the expression of Bax and Bcl-2 and enhancing caspase-3
activity in human malignant melanoma A375 cells. Int J Dermatol.
48:186–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li C, Qi Q, Lu N, Dai Q, Li F, Wang X, You
Q and Guo Q: Gambogic acid promotes apoptosis and resistance to
metastatic potential in MDA-MB-231 human breast carcinoma cells.
Biochem Cell Biol. 90:718–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi X, Chen X, Li X, Lan X, Zhao C, Liu S,
Huang H, Liu N, Liao S, Song W, et al: Gambogic acid induces
apoptosis in imatinib-resistant chronic myeloid leukemia cells via
inducing proteasome inhibition and caspase-dependent Bcr-Abl
downregulation. Clin Cancer Res. 20:151–163. 2014. View Article : Google Scholar :
|
|
11
|
Guo Q, Qi Q, You Q, Gu H, Zhao L and Wu Z:
Toxicological studies of gambogic acid and its potential targets in
experimental animals. Basic Clin Pharmacol Toxicol. 99:178–184.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan ML, Ooi JP, Ismail N, Moad AI and
Muhammad TS: Programmed cell death pathways and current antitumor
targets. Pharm Res. 26:1547–1560. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu GS: TRAIL as a target in anti-cancer
therapy. Cancer Lett. 285:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Refaat A, Abd-Rabou A and Reda A: TRAIL
combinations: The new ‘trail’ for cancer therapy (Review). Oncol
Lett. 7:1327–1332. 2014.PubMed/NCBI
|
|
15
|
Yang LJ and Chen Y: New targets for the
antitumor activity of gambogic acid in hematologic malignancies.
Acta Pharmacol Sin. 34:191–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nie F, Zhang X, Qi Q, Yang L, Yang Y, Liu
W, Lu N, Wu Z, You Q and Guo Q: Reactive oxygen species
accumulation contributes to gambogic acid-induced apoptosis in
human hepatoma SMMC-7721 cells. Toxicology. 260:60–67. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li L, Gao Y, Zhang L, Zeng J, He D and Sun
Y: Silibinin inhibits cell growth and induces apoptosis by caspase
activation, downregulating survivin and blocking EGFR-ERK
activation in renal cell carcinoma. Cancer Lett. 272:61–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spagnuolo C, Cerella C, Russo M,
Chateauvieux S, Diederich M and Russo GL: Quercetin downregulates
Mcl-1 by acting on mRNA stability and protein degradation. Br J
Cancer. 105:221–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu YL, Wan Y, Jin XJ, OuYang BQ, Bai T,
Zhao YQ and Nan JX: 25-OCH3-PPD induces the apoptosis of activated
t-HSC/Cl-6 cells via c-FLIP-mediated NF-κB activation. Chem Biol
Interact. 194:106–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu HY, Jin CY, Kim KS, Lee YC, Park SH,
Kim GY, Kim WJ, Moon HI, Choi YH and Lee JH: Oleifolioside A
mediates caspase-independent human cervical carcinoma HeLa cell
apoptosis involving nuclear relocation of mitochondrial apoptogenic
factors AIF and EndoG. J Agric Food Chem. 60:5400–5406. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He D, Xu Q, Yan M, Zhang P, Zhou X, Zhang
Z, Duan W, Zhong L, Ye D and Chen W: The NF-kappa B inhibitor,
celastrol, could enhance the anti-cancer effect of gambogic acid on
oral squamous cell carcinoma. BMC Cancer. 9:3432009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Márquez F, Babio N, Bulló M and
Salas-Salvadó J: Evaluation of the safety and efficacy of
hydroxycitric acid or Garcinia cambogia extracts in humans. Crit
Rev Food Sci Nutr. 52:585–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman MA, Kim NH and Huh SO: Cytotoxic
effect of gambogic acid on SH-SY5Y neuroblastoma cells is mediated
by intrinsic caspase-dependent signaling pathway. Mol Cell Biochem.
377:187–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Joza N, Susin SA, Daugas E, Stanford WL,
Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, et al:
Essential role of the mitochondrial apoptosis-inducing factor in
programmed cell death. Nature. 410:549–554. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim EA, Jang JH, Lee YH, Sung EG, Song IH,
Kim JY, Kim S, Sohn HY and Lee TJ: Dioscin induces
caspase-independent apoptosis through activation of
apoptosis-inducing factor in breast cancer cells. Apoptosis.
19:1165–1175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jacobson MD: Reactive oxygen species and
programmed cell death. Trends Biochem Sci. 21:83–86. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang YH, Yi MJ, Kim MJ, Park MT, Bae S,
Kang CM, Cho CK, Park IC, Park MJ, Rhee CH, et al:
Caspase-independent cell death by arsenic trioxide in human
cervical cancer cells: Reactive oxygen species-mediated
poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing
factor release from mitochondria. Cancer Res. 64:8960–8967. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishaq M, Khan MA, Sharma K, Sharma G,
Dutta RK and Majumdar S: Gambogic acid induced oxidative stress
dependent caspase activation regulates both apoptosis and autophagy
by targeting various key molecules (NF-κB, Beclin-1, p62 and NBR1)
in human bladder cancer cells. Biochim Biophys Acta.
1840:3374–3384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Palempalli UD, Gandhi U, Kalantari P,
Vunta H, Arner RJ, Narayan V, Ravindran A and Prabhu KS: Gambogic
acid covalently modifies IkappaB kinase-beta subunit to mediate
suppression of lipopolysaccharide-induced activation of NF-kappaB
in macrophages. Biochem J. 419:401–409. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Guo QL, You QD, Wu ZQ and Gu HY:
Gambogic acid induces apoptosis and regulates expressions of Bax
and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol
Pharm Bull. 27:998–1003. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Liu S, Huang H, Liu N, Zhao C, Liao
S, Yang C, Liu Y, Zhao C, Li S, et al: Gambogic acid is a
tissue-specific proteasome inhibitor in vitro and in vivo. Cell
Rep. 3:211–222. 2013. View Article : Google Scholar
|
|
32
|
Kreuz S, Siegmund D, Scheurich P and
Wajant H: NF-kappaB inducers upregulate cFLIP, a
cycloheximide-sensitive inhibitor of death receptor signaling. Mol
Cell Biol. 21:3964–3973. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Micheau O, Lens S, Gaide O, Alevizopoulos
K and Tschopp J: NF-kappaB signals induce the expression of c-FLIP.
Mol Cell Biol. 21:5299–5305. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tenev T, Bianchi K, Darding M, Broemer M,
Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K,
et al: The Ripoptosome, a signaling platform that assembles in
response to genotoxic stress and loss of IAPs. Mol Cell.
43:432–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feoktistova M, Geserick P, Kellert B,
Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Häcker G
and Leverkus M: cIAPs block Ripoptosome formation, a RIP1/caspase-8
containing intracellular cell death complex differentially
regulated by cFLIP isoforms. Mol Cell. 43:449–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JS, Li Q, Lee JY, Lee SH, Jeong JH,
Lee HR, Chang H, Zhou FC, Gao SJ, Liang C, et al: FLIP-mediated
autophagy regulation in cell death control. Nat Cell Biol.
11:1355–1362. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
He MX and He YW: A role for c-FLIP(L) in
the regulation of apoptosis, autophagy, and necroptosis in T
lymphocytes. Cell Death Differ. 20:188–197. 2013. View Article : Google Scholar :
|
|
38
|
Safa AR, Day TW and Wu CH: Cellular
FLICE-like inhibitory protein (C-FLIP): A novel target for cancer
therapy. Curr Cancer Drug Targets. 8:37–46. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Su J, Cheng H, Zhang D, Wang M, Xie C, Hu
Y, Chang HC and Li Q: Synergistic effects of 5-fluorouracil and
gambogenic acid on A549 cells: Activation of cell death caused by
apoptotic and necroptotic mechanisms via the ROS-mitochondria
pathway. Biol Pharm Bull. 37:1259–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang S, Wang L, Chen M and Wang Y:
Gambogic acid sensitizes resistant breast cancer cells to
doxorubicin through inhibiting P-glycoprotein and suppressing
survivin expression. Chem Biol Interact. 235:76–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao W, You CC, Zhuang JP, Zu JN, Chi ZY,
Xu GP and Yan JL: Viability inhibition effect of gambogic acid
combined with cisplatin on osteosarcoma cells via
mitochondria-independent apoptotic pathway. Mol Cell Biochem.
382:243–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
